Methocarbamol and Pamelor drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Methocarbamol and Pamelor. Common interactions include gastrointestinal infection among females and drug hypersensitivity among males.

The phase IV clinical study analyzes what interactions people who take Methocarbamol and Pamelor have. It is created by eHealthMe based on reports of 18 people who take Methocarbamol and Pamelor from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Jan, 30, 2023

18 people who take Methocarbamol and Pamelor together, and have interactions are studied.

What is Methocarbamol?

Methocarbamol has active ingredients of methocarbamol. It is often used in muscle spasms. eHealthMe is studying from 14,428 Methocarbamol users for its effectiveness, alternative drugs and more.

What is Pamelor?

Pamelor has active ingredients of nortriptyline hydrochloride. It is often used in migraine. eHealthMe is studying from 3,868 Pamelor users for its effectiveness, alternative drugs and more.

Number of Methocarbamol and Pamelor reports submitted per year:

Common Methocarbamol and Pamelor drug interactions by gender *:

female:

Gastrointestinal infection
Loss of consciousness
Nephrogenic anaemia
Acute respiratory failure
Adrenal mass
Ascites
Bile duct obstruction
Blood cholesterol increased
Burning mouth syndrome
Completed suicide

male:

Drug hypersensitivity
Ear pain
Headache
Neck pain
Pain in jaw
Toothache

Common Methocarbamol and Pamelor drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Ascites
Bile duct obstruction
Chronic kidney disease
Gastrooesophageal reflux disease
Jaundice
Metastases to adrenals
Metastases to lymph nodes
Nephrogenic anaemia
Pancreatic carcinoma metastatic

60+:

Chronic kidney disease
Colostomy
Completed suicide
Cystitis
Death
Diabetes mellitus
Diabetic coma
Diabetic neuropathy
Ear pain
Headache

Common conditions people have *:

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 22.22%
High Blood Pressure: 4 people, 22.22%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 16.67%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 3 people, 16.67%
Sleep Disorder: 3 people, 16.67%
Pain: 3 people, 16.67%
Diabetes: 2 people, 11.11%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 11.11%
Chest Pain: 2 people, 11.11%
Hypersensitivity: 2 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Methocarbamol and Pamelor?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.